STEIN GOLD, L. .; EYERICH, K. .; SOFEN, H. .; HERRANZ, P. .; KIRCIK, L. .; BEWLEY, T. .; WOLF, E. .; GALLO, G. .; DING, Y. .; YANG, F. E. .; PAU-CHARLES, I. .; GOODERHAM, M. . Lebrikizumab Demonstrates Consistent Efficacy at 16 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis Regardless of Baseline Disease Severity. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s274, 2023. DOI: 10.25251/skin.7.supp.274. Disponível em: https://skin.dermsquared.com/skin/article/view/2385. Acesso em: 10 jan. 2025.